Tetrahidrocurcumina: Derivado potente de la crcuma con propiedades antioxidantes, antiinflamatorias y protectoras celulares
The one completed human randomized trial (Beck et al., 2014, roughly 114 patients studied for post-operative ileus) missed its primary endpoint (p0.15)
Clemens, M
Bahr, who is prediabetic and has several other health conditions, said she was initially hesitant to use a weight-loss drug because she didn't want to be seen as "taking the easy way out" and was worried about potential side effects
A phase 2 randomised placebo controlled double-blind trial (IIH:Pressure trial) demonstrated the efficacy of exenatide at significantly reducing ICP, as measured using highly accurate telemetric ICP monitors, in people with IIH [19]
Gastrointestinal applications warrant symptom diaries, quality of life measures, and endoscopic assessment when indicated